Junfeng Zhang

1.2k total citations · 1 hit paper
43 papers, 888 citations indexed

About

Junfeng Zhang is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Junfeng Zhang has authored 43 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Junfeng Zhang's work include Cardiovascular Function and Risk Factors (13 papers), Heart Failure Treatment and Management (11 papers) and Coronary Interventions and Diagnostics (8 papers). Junfeng Zhang is often cited by papers focused on Cardiovascular Function and Risk Factors (13 papers), Heart Failure Treatment and Management (11 papers) and Coronary Interventions and Diagnostics (8 papers). Junfeng Zhang collaborates with scholars based in China, Sweden and United States. Junfeng Zhang's co-authors include Changqian Wang, Jianan Pan, Jun Gu, Huili Zhang, Jun Gu, Yuqi Fan, Hao Lin, Jianying Yu, Hui Zhang and Lin Gao and has published in prestigious journals such as Biochemical and Biophysical Research Communications, European Heart Journal and Biochemical Pharmacology.

In The Last Decade

Junfeng Zhang

42 papers receiving 874 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells

2021 142 citations Jianan Pan, Hui Zhang et al. Redox Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junfeng Zhang China	18	415	278	119	109	100	43	888
Jianan Pan China	15	320 0.8×	347 1.2×	131 1.1×	63 0.6×	61 0.6×	27	835
Shih‐Hung Chan Taiwan	18	233 0.6×	297 1.1×	108 0.9×	93 0.9×	103 1.0×	28	912
Chunlai Zeng China	20	344 0.8×	413 1.5×	106 0.9×	79 0.7×	134 1.3×	48	1.1k
Xiaolei Yang China	19	482 1.2×	396 1.4×	116 1.0×	140 1.3×	123 1.2×	98	1.2k
Ashim K. Bagchi Canada	17	340 0.8×	332 1.2×	68 0.6×	121 1.1×	171 1.7×	36	988
Liqing Jiang China	13	186 0.4×	289 1.0×	81 0.7×	62 0.6×	86 0.9×	42	717
Keke Wang China	19	234 0.6×	297 1.1×	121 1.0×	100 0.9×	96 1.0×	77	900
Tatsujiro Oka Japan	15	381 0.9×	464 1.7×	104 0.9×	105 1.0×	150 1.5×	26	1.0k
Vasiliki Tsigkou Greece	16	313 0.8×	327 1.2×	123 1.0×	150 1.4×	179 1.8×	42	1.0k
Baoxin Liu China	18	278 0.7×	368 1.3×	120 1.0×	74 0.7×	92 0.9×	61	1.1k

Countries citing papers authored by Junfeng Zhang

Since Specialization

Citations

This map shows the geographic impact of Junfeng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Zhang more than expected).

Fields of papers citing papers by Junfeng Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junfeng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Zhang. The network helps show where Junfeng Zhang may publish in the future.

Co-authorship network of co-authors of Junfeng Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Junfeng Zhang. A scholar is included among the top collaborators of Junfeng Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfeng Zhang. Junfeng Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gu, Jun, Yue Wang, Junfeng Zhang, & Changqian Wang. (2024). The impacts of prophylactic anticoagulation therapy during hospitalization on long-term cardiovascular outcomes in high-risk COVID-19 patients amid the omicron wave of the pandemic. IJC Heart & Vasculature. 50. 101353–101353. 1 indexed citations

Chen, Xin, et al.. (2024). Analysis of correlative factors of female coronary slow-flow phenomenon: A retrospective study. Medicine. 103(21). e38262–e38262.

Gu, Jun, Yue Wang, Changqian Wang, & Junfeng Zhang. (2023). The initial timing and dosage pattern of sacubitril/valsartan in patients with acute myocardial infarction undergoing percutaneous coronary intervention. European Journal of Internal Medicine. 112. 62–69. 3 indexed citations

Pan, Jianan, Hui Zhang, Hao Lin, et al.. (2023). The Imbalance of p53–Park7 Signaling Axis Induces Iron Homeostasis Dysfunction in Doxorubicin‐Challenged Cardiomyocytes. Advanced Science. 10(15). e2206007–e2206007. 50 indexed citations

Gu, Jun, et al.. (2022). Characteristics, prognosis, and treatment response in HFpEF patients with high vs. normal ejection fraction. Frontiers in Cardiovascular Medicine. 9. 944441–944441. 4 indexed citations

Zhang, Junfeng, et al.. (2021). Serum free fatty acids are associated with severe coronary artery calcification, especially in diabetes: a retrospective study. BMC Cardiovascular Disorders. 21(1). 343–343. 10 indexed citations

Guan, Ping, Jun Gu, Zhiping Song, et al.. (2021). Left Ventricular Geometry Transition in Hypertensive Patients with Heart Failure with Preserved Ejection Fraction. ESC Heart Failure. 8(4). 2784–2790. 5 indexed citations

Pan, Jianan, Hui Zhang, Hao Lin, et al.. (2021). Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells. Redox Biology. 46. 102120–102120. 142 indexed citations breakdown →

Li, Fan, Ting Sun, Yuqi Fan, et al.. (2021). The association of leukocyte telomere length and intermediate coronary lesions—a retrospective study. Annals of Palliative Medicine. 11(4). 1210–1221. 1 indexed citations

10.

Pan, Jianan, Hui Zhang, Quan Yu, et al.. (2021). Association of Circulating Irisin Levels and the Characteristics and Prognosis of Coronary Artery Disease. The American Journal of the Medical Sciences. 362(1). 63–71. 23 indexed citations

11.

Pan, Jianan, Hao Lin, Changqian Wang, Junfeng Zhang, & Jun Gu. (2020). Association between long-term prescription of febuxostat and the progression of heart failure with preserved ejection fraction in patients with hypertension and asymptomatic hyperuricemia. Heart and Vessels. 35(10). 1446–1453. 12 indexed citations

12.

Gu, Jun, Zhuo Yang, Tianjiao Liu, et al.. (2020). Balloon Deflation Strategy during Primary Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Clinical Trial and Numerical Simulation-Based Analysis. Cardiology Research and Practice. 2020. 1–10. 2 indexed citations

13.

Fan, Li, Jianan Pan, Hao Lin, et al.. (2020). Optimal management of blood glucose, blood pressure and atrial fibrillation to reduce the risk of heart failure with preserved ejection fraction. Internal Medicine Journal. 52(2). 301–309. 2 indexed citations

14.

Gu, Jun, Zhaofang Yin, Junfeng Zhang, & Changqian Wang. (2019). Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension. International Journal of Cardiology. 306. 140–145. 26 indexed citations

15.

Zhang, Tiantian, Lin Gao, Xiaofei Wang, et al.. (2019). MicroRNA-146a protects against myocardial ischaemia reperfusion injury by targeting Med1. Cellular & Molecular Biology Letters. 24(1). 62–62. 22 indexed citations

16.

Gao, Lin, Tiantian Zhang, Yue Wang, et al.. (2019). MicroRNA-21 deficiency attenuated atherogenesis and decreased macrophage infiltration by targeting Dusp-8. Atherosclerosis. 291. 78–86. 32 indexed citations

17.

Gu, Jun, Jianan Pan, Yuqi Fan, et al.. (2018). Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus. Cardiovascular Diabetology. 17(1). 96–96. 40 indexed citations

18.

Gu, Jun, Yuqi Fan, Zhihua Han, et al.. (2016). Association between long-term prescription of aldosterone antagonist and the progression of heart failure with preserved ejection fraction in hypertensive patients. International Journal of Cardiology. 220. 56–60. 19 indexed citations

19.

Shen, Ying‐Hao, Junfeng Zhang, Jing Zhou, et al.. (2013). Influences of gender, age, and body mass index on the arterial stiffness in hypertensive patients. 15(4). 465–468. 1 indexed citations

20.

Zhang, Qi, Ruiyan Zhang, Jianping Qiu, et al.. (2008). Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction. Chinese Medical Journal. 121(6). 485–491. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact